Penn Medicine Abramson Cancer Center


 

bsAb and IO for R/R MM in 2021: Are Teclistamab, Talquetamab, & Cevostamab Showing Promising Activity?

31 views
March 2, 2021
Comments 0
Login to view comments. Click here to Login